Franklin, MA, United States of America

Dongling Su

USPTO Granted Patents = 19 

 

 

Average Co-Inventor Count = 3.4

ph-index = 7

Forward Citations = 97(Granted Patents)


Location History:

  • Dorchester, MA (US) (2011)
  • Franklin, MA (US) (2010 - 2021)

Company Filing History:


Years Active: 2010-2021

Loading Chart...
Loading Chart...
Loading Chart...
19 patents (USPTO):Explore Patents

Title: **Dongling Su: Innovator in Joint Treatment Solutions**

Introduction

Dongling Su, based in Franklin, MA, is a prominent inventor recognized for his significant contributions to medical innovations, particularly in the field of joint treatment. With a remarkable portfolio that includes 19 patents, Su's work focuses on the development of compositions and methods aimed at alleviating joint conditions such as osteoarthritis.

Latest Patents

Among Su's notable patents are two innovative approaches for treating joint conditions. These patents detail compositions that utilize hyaluronic acid (HA) in combination with a lyophilized second component designed to temporarily reduce the viscosity of HA. The second component may include various glycosaminoglycans (GAGs), such as chondroitin sulfate, dermatan sulfate, heparin, and keratan sulfate. The applications of these compositions extend to various synovial joints, including the knee, shoulder, and hip, providing relief from pain and slowing disease progression. Additionally, his inventions encompass the use of glucosamine as an effective supplement in these compositions.

Career Highlights

Throughout his career, Dongling Su has made significant strides in the medical device industry, particularly through his work with internationally recognized companies like DePuy Mitek, Inc. and Advanced Technologies and Regenerative Medicine, LLC. His expertise and innovative mindset have allowed him to impact the field substantially, particularly in developing advanced treatments for joint-related ailments.

Collaborations

Su has collaborated with notable professionals in the industry, including Julia Hwang and Julius Lopez. These partnerships reflect his commitment to pushing the boundaries of medical research and innovation, enabling him to combine diverse expertise to enhance the effectiveness of his patents.

Conclusion

Dongling Su's contributions to joint treatment technologies underscore the vital role of innovation in the medical field. His patents not only signify advancements in the therapeutic management of osteoarthritis but also highlight the importance of collaboration and interdisciplinary approaches in achieving successful outcomes for patients. As he continues to develop more solutions, Su remains a key figure in the quest for improved health and well-being among individuals suffering from joint conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…